News

With 44% stake, Candel Therapeutics, Inc. (NASDAQ:CADL) seems to have captured institutional investors' interest

NasdaqGM:CADL 1 Year Share Price vs Fair Value Explore Candel Therapeutics's Fair Values from the Community and ...